You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: October 19, 2020

DrugPatentWatch Database Preview

Details for Patent: 10,097,388

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,097,388
Title:Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
Abstract: A method may include receiving a signal. The signal may encode a data packet. The method may include further sampling the signal to generate sampled values, and generating a slice record comprising a plurality of slices from the sampled values by correlating the sampled values with first and second reference templates. The first reference template may include a first reference function, and the second reference template may include a second reference function in quadrature with the first reference function. The method may further include cross-correlating the slice record with a stored template to generate cross-correlation terms, and determining when a magnitude of the cross-correlation terms exceeds a predetermined threshold for a width of the stored template.
Inventor(s): Fleming; Robert (Nicasio, CA), Kushner; Cherie (Nicasio, CA), McAllister; William H. (Saratoga, CA), Zdeblick; Mark (Portola Valley, CA)
Assignee: PROTEUS DIGITAL HEALTH, INC. (Redwood City, CA)
Application Number:15/678,349
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 10,097,388

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,097,388

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014321320   Start Trial
Australia 2019204197   Start Trial
Canada 2924815   Start Trial
Canada 2965941   Start Trial
China 105556912   Start Trial
China 110098914   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.